To our knowledge, the effect of ACEi and ARBs on disease activity in larger groups of RA patients, measured with the disease activity score28 using C-reactive protein (DAS28-CRP), has not been investigated so far. This evidence concerns the gene CRP and rheumatoid arthritis.